Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.
Lack of Assurance of Sterility
Quick Facts at a Glance
- Recall Date
- April 20, 2026
- Hazard Level
- HIGH
- Brands
- OPTASE, Scope Health Inc
- Geographic Scope
- 1 states
Hazard Information
Lack of Assurance of Sterility
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact SCOPE HEALTH or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for OPTASE recalls
Be the first to know. Free instant alerts to your inbox.
Full Description
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.. Generic: GLYCERIN; Brand: OPTASE. Reason: Lack of Assurance of Sterility. Classification: Class II. Distribution: Nationwide within the United States
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: How to Get Refunds and ReplacementsWant to Know First?
Get instant alerts for recalls that affect you. Free forever.